Faced with a dramatically poor prognosis for their daughter, Elizabeth Buell-Fleming's parents were pulled back from the cliff by an investigational monoclonal antibody.
A 12-year survivor of stage 3B lung cancer, Tomma Hargraves uses her experience and training as a patient lay navigator to help others diagnosed with the disease.
During a clinical trial for the immunotherapeutic nivolumab, Philip found the quality of his life "improved monthly."
School counselor Diane Nathaniel creates communities for herself and those around her in Brooklyn and beyond. Her colon cancer diagnosis at the age of 44 led her to patient advocacy.
When his melanoma spread, Bob turned to a clinical trial of an investigational, local immunotherapy called T-Vec.
Before surgery, chemotherapy, and radiation therapy for her stage 3 breast cancer, Christine Cosby participated in a prehabilitation trial that she credits with helping her bother physically and mentally for her treatments.
Cancer research has enabled Kirby Lewis to live productively with metastatic breast cancer. “I hope that by sharing my story I can show others that life doesn't end when you get a terminal diagnosis; it is still well worth living.”
After her own fight against cancer, Melanie Nix works to help other breast cancer patients and advocates in support of cancer research.
Diagnosed at 8 years of age, Meisha "knew what I had was pretty bad because all my visitors - were tearful."
When her cancer spread to her lungs, Christina McEvoy, the mother of two young boys, sought the state-of-the-art treatments that would give her the best chance to beat her disease.